カテゴリ： MarketLine, インドネシア, 企業調査

PT Paninvest Tbk：企業の戦略・SWOT・財務情報

◆英語タイトル：PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C11849
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：23
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：インドネシア
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

PT Paninvest Tbk – Strategy, SWOT and Corporate Finance Report
Summary

PT Paninvest Tbk – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PT Paninvest Tbk (Paninvest), formerly known as PT Panin Insurance Tbk, focuses on tourism and life insurance business. It offers life insurance products such as whole life insurance, unit linked insurance, death insurance, endowment plans, health insurance, personal accident insurance and annuities. It also offers tourism; trading and services; and manual funds. The company, through its products and serves its clientele comprising individuals and corporate customers. The company markets and distributes its products through a network of branches, bancassurance channel, insurance advisors, and marketing offices across the country. The company is a part of Panin Group, a provider of financial services. Paninvest is headquartered in Jakarta, Indonesia.

The company reported gross premiums of IDR3,602.7 billion during fiscal year ended December 2016 (FY2016), a decrease of 4.6% over FY2015. It reported net premium revenues of IDR3,526 billion in FY2016, a decrease of 1.8% over FY2015.

Scope

- Detailed information on PT Paninvest Tbk required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PT Paninvest Tbk in the form of a SWOT analysis
- An in-depth view of the business model of PT Paninvest Tbk including a breakdown and examination of key business segments
- Intelligence on PT Paninvest Tbk’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PT Paninvest Tbk, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PT Paninvest Tbk and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PT Paninvest Tbk as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PT Paninvest Tbk’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
PT Paninvest Tbk: Company Overview 6
PT Paninvest Tbk: Overview and Key Facts 6
PT Paninvest Tbk: Overview 6
PT Paninvest Tbk: Key Facts 6
PT Paninvest Tbk: Key Employees 8
PT Paninvest Tbk: Key Employee Biographies 9
PT Paninvest Tbk: Major Products and Services 10
PT Paninvest Tbk: Company History 11
PT Paninvest Tbk: Management Statement 13
PT Paninvest Tbk: Locations and Subsidiaries 15
PT Paninvest Tbk: Key Competitors 16
PT Paninvest Tbk: Company Analysis 17
PT Paninvest Tbk: Business Description 17
PT Paninvest Tbk: SWOT Analysis 18
PT Paninvest Tbk: SWOT Overview 18
PT Paninvest Tbk: Strengths 18
PT Paninvest Tbk: Weaknesses 19
PT Paninvest Tbk: Opportunities 19
PT Paninvest Tbk: Threats 20
Appendix 21
Contact Us 21
Methodology 21
About MarketLine 22

List of Tables
Table 1: PT Paninvest Tbk: Key Facts
Table 2: PT Paninvest Tbk: Key Employees
Table 3: PT Paninvest Tbk: Company History
Table 4: PT Paninvest Tbk: Locations and Subsidiaries
Table 5: PT Paninvest Tbk: Key Competitors



★海外企業調査レポート[PT Paninvest Tbk：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Eiger BioPharmaceuticals Inc (EIGR)：企業の財務・戦略的SWOT分析
    Summary Eiger BioPharmaceuticals Inc (Eiger), formerly Celladon Corp is a clinical-stage biopharmaceutical company that focuses on the development and commercializationof novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which are …
  • Pan Malaysia Holdings Berhad：企業の戦略・SWOT・財務分析
    Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Pan Malaysia Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Boparan Holdings Ltd：企業の戦略的SWOT分析
    Boparan Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Westpac Banking Corporation：企業のM&A・事業提携・投資動向
    Westpac Banking Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Westpac Banking Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Shanghai Medicilon Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Shanghai Medicilon Inc (Medicilon) is a drug discovery company that offers integrated services across biology, preclinical, chemistry, and drug discovery processes. The company provides chemistry services such as process development, medicinal chemistry, synthesis chemistry, and analytical c …
  • LRAD Corporation：企業の戦略・SWOT・財務情報
    LRAD Corporation - Strategy, SWOT and Corporate Finance Report Summary LRAD Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • FirstCaribbean International Bank Limited：企業の戦略的SWOT分析
    FirstCaribbean International Bank Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • PTT Global Chemical Public Co Ltd (PTTGC)：企業の財務・戦略的SWOT分析
    PTT Global Chemical Public Co Ltd (PTTGC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Intech Biopharm Ltd (6461)：製薬・医療：M&Aディール及び事業提携情報
    Summary Intech Biopharm Ltd (Intech Biopharm) is a drug developing company that develops drugs for obstructive airway diseases. The company provides marketed products such as single ingredient generics such as Synvent, and Duasma, developed for asthma; and multi-ingredient generic, Synflutide, for a …
  • San Juan Basin Royalty Trust (SJT)：企業の財務・戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) is a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include royalty interests, overriding royalty i …
  • PT PLN (Persero)-エネルギー分野：企業M&A・提携分析
    Summary PT PLN (Persero) (PLN) is a state-owned power company that generates, transmits and distributes electricity. It generates power from various sources including coal, natural gas and oil fuel based steam power plants. The company also offers electricity support services such as electricity con …
  • SDL plc (SDL)：企業の財務・戦略的SWOT分析
    Summary SDL Plc (SDL) is a technology solution provider that offers language translation technology, services, and content management services. The company’s products include live content architect, live content create, media manager, idiom world server, campaign analytics, email manager, language w …
  • Sibanye Gold Ltd：戦略・SWOT・企業財務分析
    Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sibanye Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Activision Blizzard, Inc.
    Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report Summary Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • salesforce.com, inc.：戦略・SWOT・企業財務分析
    salesforce.com, inc. - Strategy, SWOT and Corporate Finance Report Summary salesforce.com, inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tri Chemical Laboratories, Inc. (4369)：企業の財務・戦略的SWOT分析
    Tri Chemical Laboratories, Inc. (4369) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Cellmid Ltd (CDY)：企業の財務・戦略的SWOT分析
    Summary Cellmid Ltd (Cellmid) formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such as …
  • Boston Scientific Corp (BSX)：企業の財務・戦略的SWOT分析
    Boston Scientific Corp (BSX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Blackthorn Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Blackthorn Therapeutics Inc (Blackthorn Therapeutics) is a clinical stage biopharmaceutical company that discovers and develops targeted treatments for neurobehavioral disorders. The company offers products such as BTRX-246040, an NOPR antagonist; and BTRX-335140, a KOR antagonist. It uses I …
  • Sulzer Ltd (SUN)：電力：M&Aディール及び事業提携情報
    Summary Sulzer Ltd (Sulzer) is an industrial engineering company that manufactures and supplies pump equipment. It offers mixers, compressors, agitators and aeration equipment. The company provides repair and maintenance service solutions for turbines, pumps, compressors, motors, and generators. Sul …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆